EUVIMEDEUVIMED entdecken
Crossref

Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion

Chang Joo Oh, Min-Ji Kim, Ji-Min Lee, Dong Hun Kim, Il-Young Kim, Sanghee Park, Yeongmin Kim, Kyung-Bok Lee, Sang-Hee Lee, Chae Won Lim, Myeongjin Kim, Jung-Yi Lee und 10 weitere

Kidney International · 2023-10 · 104 (4) · 724-739

DOI: 10.1016/j.kint.2023.06.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2023-10. Verfasst von Chang Joo Oh und 21 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Aging and Metabolism, Kyungpook National University School of Medicine, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Succinic Acid, Reperfusion Injury. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia-reperfusion (IR) injury, a leading cause of acute kidney injury (AKI), is still without effective therapies. Succinate accumulation during ischemia followed by its oxidation during reperfusion leads to excessive reactive oxygen species (ROS) and severe kidney damage. Consequently, the targeting of succinate accumulation may represent a rational approach to the prevention of IR-induced kidney injury. Since ROS are generated primarily in mitochondria, which are abundant in the proximal tubule of the kidney, we explored the role of pyruvate dehydrogenase kinase 4 (PDK4), a mitochondrial enzyme, in IR-induced kidney injury using proximal tubule cell-specific Pdk4 knockout (Pdk4ptKO) mice. Knockout or pharmacological inhibition of PDK4 ameliorated IR-induced kidney damage. Succinate accumulation during ischemia, which is responsible for mitochondrial ROS production during reperfusion, was reduced by PDK4 inhibition. PDK4 deficiency established conditions prior to ischemia resulting in less succinate accumulation, possibly because of a reduction in electron flow reversal in complex II, which provides electrons for the reduction of fumarate to succinate by succinate dehydrogenase during ischemia. The administration of dimethyl succinate, a cell-permeable form of succinate, attenuated the beneficial effects of PDK4 deficiency, suggesting that the kidney-protective effect is succinate-dependent. Finally, genetic or pharmacological inhibition of PDK4 prevented IR-induced mitochondrial damage in mice and normalized mitochondrial function in an in vitro model of IR injury. Thus, inhibition of PDK4 represents a novel means of preventing IR-induced kidney injury, and involves the inhibition of ROS-induced kidney toxicity through reduction in succinate accumulation and mitochondrial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Succinic AcidReperfusion InjuryMiceAnimalsReactive Oxygen SpeciesMice, KnockoutIschemiaKidneyMitochondriaReperfusionProtein Kinases

Stichwörter der Autor:innen

acute kidney failureischemia-reperfusion injurymitochondrial dysfunctionpyruvate dehydrogenase kinase 4reactive oxygen speciessuccinate accumulation

Substanzen

Succinic AcidReactive Oxygen Speciespyruvate dehydrogenase kinase 4Protein Kinases

Autor:innen und Institutionen

  • Research Institute of Aging and Metabolism, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
  • Department of Internal Medicine, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Molecular Medicine, College of Medicine, Gachon University, Incheon, Republic of Korea; Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Repub…
  • Department of Exercise Rehabilitation, Gachon University, Incheon, Republic of Korea.

Zitieren

APA

Oh, C. J., Kim, M. J., Lee, J. M., Kim, D. H., Kim, I. Y., Park, S., Kim, Y., Lee, K. B., Lee, S. H., Lim, C. W., Kim, M., Lee, J. Y., Pagire, H. S., Pagire, S. H., Bae, M. A., Chanda, D., Thoudam, T., Khang, A. R., Harris, R. A., …, & Lee, I. K. (2023). Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion. Kidney International, 104(4), 724-739. https://doi.org/10.1016/j.kint.2023.06.022

Vancouver

Oh CJ, Kim MJ, Lee JM, Kim DH, Kim IY, Park S, et al. Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion. Kidney International. 2023;104(4):724-739. doi:10.1016/j.kint.2023.06.022

BibTeX
@article{Oh2023,
  author = {Oh, Chang Joo and Kim, Min-Ji and Lee, Ji-Min and Kim, Dong Hun and Kim, Il-Young and Park, Sanghee and Kim, Yeongmin and Lee, Kyung-Bok and Lee, Sang-Hee and Lim, Chae Won and Kim, Myeongjin and Lee, Jung-Yi and Pagire, Haushabhau S and Pagire, Suvarna H and Bae, Myung Ae and Chanda, Dipanjan and Thoudam, Themis and Khang, Ah Reum and Harris, Robert A and Ahn, Jin Hee and Jeon, Jae-Han and Lee, In-Kyu},
  title = {Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion},
  journal = {Kidney International},
  year = {2023},
  volume = {104},
  number = {4},
  pages = {724--739},
  doi = {10.1016/j.kint.2023.06.022}
}
Kostenlos starten →